SECURITY AGREEMENTSecurity Agreement • March 27th, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
THIS SECURITY AGREEMENT (this “Agreement”), dated as of March 21, 2018, is executed by Jaguar Health, Inc., a Delaware corporation (“Debtor”), in favor of Chicago Venture Partners, L.P., a Utah limited partnership (“Secured Party”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 27th, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 21, 2018, is entered into by and between JAGUAR HEALTH, INC., a Delaware corporation (“Company”), and CHICAGO VENTURE PARTNERS, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
ContractJaguar Health, Inc. • March 27th, 2018 • Pharmaceutical preparations • Utah
THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES IN THE UNITED STATES. THIS NOTE IS SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.
SERIES A PREFERRED STOCK PURCHASE AGREEMENT BETWEEN JAGUAR HEALTH, INC. (COMPANY) AND SAGARD CAPITAL PARTNERS, L.P. (PURCHASER) DATED: MARCH 23, 2018Series a Preferred Stock Purchase Agreement • March 27th, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • Delaware
THIS SERIES A PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of the 23rd day of March, 2018 by and between Jaguar Health, Inc. a company incorporated under the laws of Delaware (the “Company”) and Sagard Capital Partners L.P., a Delaware limited partnership (the “Purchaser”).
FORM OF SHARE PURCHASE AGREEMENTShare Purchase Agreement • March 27th, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • California
THIS SHARE PURCHASE AGREEMENT (the “Agreement”) is deemed to be effective as of March 23, 2018 (the “Effective Date”), by and among Jaguar Health, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, a “Purchaser” and collectively, the “Purchasers”).
MANAGEMENT SERVICES AGREEMENTManagement Services Agreement • March 27th, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • Delaware
This Management Services Agreement (this “Agreement”) is entered into as of March 23, 2018 (the “Commencement Date”) by and between Jaguar Health, Inc., a Delaware corporation (the “Company”), and Sagard Capital Partners Management Corp., a Delaware corporation (“Sagard Management”).
REGISTRATION RIGHTS AGREEMENT by and between JAGUAR HEALTH, INC. and SAGARD CAPITAL PARTNERS, L.P. Dated as of March 23, 2018Registration Rights Agreement • March 27th, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 23, 2018, is by and between Jaguar Health, Inc., a Delaware corporation (the “Company”), and the undersigned Purchaser (the “Purchaser”).
